产品
  • 产品
  • 供应商
  • 采购
  • 资讯
  • 会展
首页 制药产品大全 药品制剂 Ceftriaxone Sod...

Ceftriaxone Sodium for Injection 1g

2025-06-04
宁波市

产品详情

Ceftriaxone Sodium for Injection 1g
抗菌药与抗病毒药制剂
Ceftriaxone Sodium for Injection
中/南美洲,东欧,亚洲,中东,非洲

产品描述

Ceftriaxone Sodium for Injection

Specification1g 10vials/ Tray/Box
Shelf life3years
StorageStore below 30°C.



Therapeutic indications
For lower respiratory tract infections caused by sensitive pathogens, urinary tract, biliary tract infections, as well as abdominal infections, pelvic infections, skin and soft tissue infections, bone and joint infections, sepsis, meningitis, etc. and prevention of infection during surgery. This product can treat simple gonorrhea in a single dose.
Dose and method of administration
 General infection, 1g daily, 1 intramuscular injection or intravenous injection. Severe infection, 2g daily, given in 2 divided doses. Meningitis can be given in two doses of 100 mg/kg per day (but not more than 4 g in total). Gonorrhea, a single dose of 250mg is sufficient. The amount of children is generally given in 1/2 of the adult amount. Intramuscular injection: One dose is dissolved in an appropriate amount of 0.5% lidocaine hydrochloride injection for deep intramuscular injection. Intravenous injection: Dissolve 1 g of the drug in 10 ml of sterile water for injection and slowly inject for 2-4 minutes. Intravenous infusion: 1 g in an adult or 2 g in 1 day, dissolved in isotonic sodium chloride injection or 50-100 ml of 5%-10% glucose solution, and instilled within 0.5-1 hour.
Adverse reactions
Adverse reactions are related to the dose and course of treatment. Local reactions include phlebitis (1.86%), in addition to rash, itching, fever, bronchospasm and serum sickness (2.77%), headache or dizziness (0.27%), diarrhea, nausea, vomiting, abdominal pain, colitis Digestive tract reactions such as jaundice, flatulence, taste disturbance and indigestion (3.45%). Laboratory abnormalities were about 19%, with abnormal hematology accounting for 14%, including eosinophilia, thrombocytosis or reduction, and leukopenia. Patients with abnormal liver and kidney function were 5% and 1.4%.
****Follow all directions given to you by your doctor and pharmacist carefully


宁波信华医药科技有限公司
访问店铺
注册资本
公司地址
联系人

公司简介

Ningbo Sinofin Pharmaceutical Co., Ltd. was established in the year of 2015 and is specialized in production, R&D and marketing of Human and Veterinary Pharmaceutical products. With our professional team, we have successfully registered and sold our products globally. Most of the products are under our own Trade Mark (SINOFIN, VOICE & TISUMEC).The company takes all measures to focus on customers satisfaction and provide them with high quality and affordable products.
业务类型:
成立日期:
年营业额:
主营产品类别: